AbGenesis is our flagship world-leading computational immunology platform for mining of antibodies, TCRs and peptides. Built in 2012, it immediately attracted multiple clients and enabled us to become profitable in our first year of business. AbGenesis is now used at over 30 institutions and biotechnology companies, including 6 of the 10 top pharma. Internally, AbGenesis acts synergistically to empower our antibody library and vaccine programs.
Get a License